Last reviewed · How we verify
The Effect of the Type of Ovarian Stimulation Protocol on PGD Results: a Prospective Randomised Trial (Avanti)
The aim of our study is to define the optimal ovarian stimulation protocol concerning PGD and for this reason we plan a randomized controlled trial (RCT) comparing gonadotropin-releasing hormone (GnRH) agonist protocol versus GnRH antagonist protocol. The follicle stimulating hormone (FSH) preparation in both arms will be highly purified FSH (Menopur®).
Details
| Lead sponsor | Universitair Ziekenhuis Brussel |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 120 |
| Start date | 2010-09 |
| Completion | 2013-06 |
Conditions
- Reproductive Endocrinology
- Fertility
- Optimal Stimulation Protocol
Interventions
- GnRH agonist
- GnRH antagonist
- hP-hMG
- Human chorionic gonadotropin
- Progesterone
Primary outcomes
- Number of day 3 embryos for biopsy available — up to 6 weeks
Countries
Belgium